Vaximm AG - Company Review
Vaximm AG - Company ReviewSummary
Vaximm AG (Vaximm) is a biotechnology company which focuses on developing active immunotherapies (vaccines). The company’s pipeline product includes VXM01, VXM04, VXM NEO, VXM06 and VXM08, among others. Its products are developed for treating patients with advanced pancreatic cancer, colorectal cancer and for certain other cancer indications. Vaximm developed a technology based on oral T-cell activators which can be readily adapted to target a wide range of cancer-related antigens. The company’s oral vaccines are ingested for cellular immune response such as specific cytotoxic T-cells against the targets to destroy tumor stroma cells in the patients' body. It has presence in Mannheim, Germany. Vaximm is headquartered in Basel, Switzerland.
This comprehensive company report of Vaximm AG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.